Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 26, 2026 08:00 ET | Source: Vaxart, Inc.

Vaxart Publishes Presentation Urging Shareholders to Vote “FOR” ALL Six of the Company’s Highly Qualified Director Nominees on the WHITE Proxy Card TODAY

Details Strategic Actions Taken by the Board to Advance the Company’s Pipeline and Drive Value Creation Vaxart’s Purpose-Built Board Brings the Proven Expertise Needed to Oversee its Next Phase of...
June 26, 2026 06:46 ET | Source: Bleichmar Fonti & Auld

$EMBC Fraud Alert: Embecta Investors Sue for Recovery in Securities Fraud Class Action after 57% Stock Drop – Investors Notified to Contact BFA Law

Embecta Investors Sue for Recovery in Securities Fraud Class Action after 57% Stock Drop – Investors Notified to Contact BFA Law
June 25, 2026 19:07 ET | Source: The Rosen Law Firm PA

ROSEN, A LEADING NATIONAL FIRM, Encourages Embecta Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – EMBC

NEW YORK, June 25, 2026 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Embecta Corp....
June 25, 2026 15:41 ET | Source: Robbins LLP

EMBC Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Embecta Corp. Class Action Lawsuit

Robbins LLP is Investigating Allegations that Embecta Corp. (EMBC) Misled Investors Regarding its Business Prospects
June 25, 2026 13:42 ET | Source: MDaudit

KLAS Emerging Insights: MDaudit Customers Award A+ Ratings for AI-powered Continuous Risk Monitoring Platform

MDaudit customers interviewed for KLAS Research’s First Look gave the company’s AI-powered continuous risk monitoring platform A+ ratings across most KPIs.
June 25, 2026 09:00 ET | Source: Milestone Scientific, Inc.

Milestone Scientific Strengthens Board to Support Next Phase of Growth

ROSELAND, N.J., June 25, 2026 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections,...
June 25, 2026 08:00 ET | Source: Vaxart, Inc.

Vaxart Announces Update to BARDA Funding Award to Reflect Current Scope of COVID-19 Oral Pill Vaccine Trial

Latest Modification is Important Required Step to Releasing 12-month Data from 400-participant Sentinel Cohort Funding to Advance Data Analysis from More Than 5,000 Trial Participants Ahead of Key...
June 25, 2026 07:00 ET | Source: Atea Pharmaceuticals, Inc.

Atea Pharmaceuticals Completes Patient Enrollment in Phase 3 C-FORWARD Trial Evaluating Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus

Topline Phase 3 Results from C-FORWARD Expected Around Year-End 2026 More Than 880 HCV Treatment-Naïve Patients Enrolled Across 17 Countries Outside North America C-FORWARD and C-BEYOND Represent...
June 25, 2026 04:30 ET | Source: SNS Insider pvt ltd

Breast Cancer Liquid Biopsy Market Size to Reach USD 3.42 Billion by 2035 | SNS Insider

Austin, United States, June 25, 2026 (GLOBE NEWSWIRE) -- According to SNS Insider, the Breast Cancer Liquid Biopsy Market Size was valued at USD 1.33 Billion in 2025 and is projected to reach USD...
June 24, 2026 22:30 ET | Source: Custom Market Insights

[Latest] Global Therapeutic Apheresis Market Size/Share Worth USD 8.94 Billion by 2035 at a 7.9% CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Austin, TX, USA, June 25, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Therapeutic Apheresis Market Size, Trends and Insights By Product Type (Apheresis...